Publication:
Molecular genetic heterogeneity in undifferentiated endometrial carcinomas.

dc.contributor.authorRosa-Rosa, Juan M
dc.contributor.authorLeskelä, Susanna
dc.contributor.authorCristóbal-Lana, Eva
dc.contributor.authorSantón, Almudena
dc.contributor.authorLópez-García, Ma Ángeles
dc.contributor.authorMuñoz, Gloria
dc.contributor.authorPérez-Mies, Belen
dc.contributor.authorBiscuola, Michele
dc.contributor.authorPrat, Jaime
dc.contributor.authorEsther, Oliva
dc.contributor.authorSoslow, Robert A
dc.contributor.authorMatias-Guiu, Xavier
dc.contributor.authorPalacios, Jose
dc.date.accessioned2023-01-25T08:35:09Z
dc.date.available2023-01-25T08:35:09Z
dc.date.issued2016-08-05
dc.description.abstractUndifferentiated and dedifferentiated endometrial carcinomas are rare and highly aggressive subtypes of uterine cancer, not well characterized at a molecular level. To investigate whether dedifferentiated carcinomas carry molecular genetic alterations similar to those of pure undifferentiated carcinomas, and to gain insight into the pathogenesis of these tumors, we selected a cohort of 18 undifferentiated endometrial carcinomas, 8 of them with a well-differentiated endometrioid carcinoma component (dedifferentiated endometrioid carcinomas), and studied them by immunohistochemistry and massive parallel and Sanger sequencing. Whole-exome sequencing of the endometrioid and undifferentiated components, as well as normal myometrium, was also carried out in one case. According to The Cancer Genome Atlas classification, we distributed 95% of the undifferentiated carcinomas in this series as follows: (a) hypermutated tumors with loss of any mismatch repair protein expression and microsatellite instability (eight cases, 45%); (b) ultramutated carcinomas carrying mutations in the exonuclease domain of POLE (two cases, 11%); (c) high copy number alterations (copy-number high) tumors group exhibiting only TP53 mutations and high number of alterations detected by FISH (two cases, 11%); and (d) low copy number alterations (copy-number low) tumors with molecular alterations typical of endometrioid endometrial carcinomas (five cases, 28%). Two of the latter cases, however, also had TP53 mutations and higher number of alterations detected by FISH and could have progressed to a copy-number high phenotype. Most dedifferentiated carcinomas belonged to the hypermutated group, whereas pure undifferentiated carcinomas shared molecular genetic alterations with copy-number low or copy-number high tumors. These results indicate that undifferentiated and dedifferentiated endometrial carcinomas are molecularly heterogeneous tumors, which may have prognostic value.
dc.identifier.doi10.1038/modpathol.2016.132
dc.identifier.essn1530-0285
dc.identifier.pmcPMC5708881
dc.identifier.pmid27491810
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708881/pdf
dc.identifier.unpaywallURLhttps://www.nature.com/articles/modpathol2016132.pdf
dc.identifier.urihttp://hdl.handle.net/10668/10337
dc.issue.number11
dc.journal.titleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
dc.journal.titleabbreviationMod Pathol
dc.language.isoen
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number1390-1398
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subject.meshCarcinoma, Endometrioid
dc.subject.meshDNA Mutational Analysis
dc.subject.meshEndometrial Neoplasms
dc.subject.meshFemale
dc.subject.meshHumans
dc.titleMolecular genetic heterogeneity in undifferentiated endometrial carcinomas.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number29
dspace.entity.typePublication

Files